Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/228208


Commercial Insight: Asthma and COPD - Control is the Goal


Description: The world market for asthma/COPD drugs, valued at $13.3 billion in 2003, is forecast to grow to $19.0 billion by 2009, driven by the expansion of combination steroid/bronchodilator products into a wider spectrum of patients, and strong growth in COPD specific therapies. GlaxoSmithKline and Merck remain the indisputable leaders in asthma, with Pfizer steadily building a presence in COPD. Scope - Outlook for the asthma/COPD market, including key events impacting combination products, leukotriene antagonists, and anticholinergics Global sales forecasts to 2014, including country-specific forecasts for the US, Japan, France, Germany, Italy, Spain and the UK Review of global and country specific opportunities and threats impacting key brands, including Seretide, Symbicort, Singulair, Spiriva, and Daxas Case studies on Seretides promotional strategies on redefining asthma management, and building Xopenexs primary care presence Highlights - GSK has added fresh impetus to Seretide growth by focusing on the control of asthma, rather than symptom severity, enabling Seretide to appeal to the full spectrum of patients and move beyond moderate to severe asthma. The growth of Spiriva and Daxas will add breadth to an underdeveloped market and establish Pfizer as the premier company in COPD, which is the fastest growing segment of the market. Landmark morbidity and mortality trials, improved awareness, diagnosis and earlier therapeutic intervention, indicates a very promising outlook for this disease. The dominance of Seretide and Singulair is not likely to be challenged in the foreseeable future, although the large market size, with few NCEs, makes it possible for companies to successfully launch niche products through effective patient targeting. Reasons to Purchase - Evaluate the expansion of combination products into a wider spectrum of patients through new indications and promotional activities Quantify the future size and scope of the asthma/COPD market and predict the future performance of key compounds Examine the impact of future patent expiries in each of the seven country markets


Contents: CHAPTER 1 EXECUTIVE SUMMARY 3 Objective of the analysis 3 Our insight into the disease market 3 CHAPTER 2 MARKET DEFINITION AND OVERVIEW 8 Market definition for this report 8 Current market situation 9 Strategic scoping and focus 15 CHAPTER 3 COUNTRY MARKET ASSESSMENTS 16 Current and future opportunities and threats in the asthma/COPD market 16 Global opportunities and threats 16 Opportunities 16 Threats 19 US: opportunities and threats 24 Opportunities 24 Threats 25 Japan: opportunities and threats 27 Opportunities 27 Threats 28 France: opportunities and threats 31 Opportunities 31 Threats 32 Germany: opportunities and threats 32 Opportunities 32 Threats 33 Italy: opportunities and threats 34 Opportunities 34 Threats 34 Spain: opportunities and threats 36 Opportunities 36 Threats 36 UK: opportunities and threats 37 Opportunities 37 Threats 39 CHAPTER 4 FORECAST ANALYSIS 42 Assumptions and events 42 Combination class 43 Oral anti-inflammatories class 54 Long & short B2-agonist class 55 Anti-muscarinic class 57 Biological class 58 Limitations of data 59 Forecasts 60 CHAPTER 5 COMMERCIAL IMPACT AND LIFECYCLE MANAGEMENT: CASE STUDIES 61 Introduction 61 Case studies 61 Advair – redefining the approach to asthma management 61 Sepracor – building a primary care presence 65 APPENDIX A – MARKET DATA AND MAJOR BRAND KEY FACTS 70 Global disease market data 70 Combination ICS/LABA 71 Oral non-steroidal anti-inflammatories 73 Inhaled corticosteroids 74 Long-acting bronchodilators 76 Long-acting anti-cholinergics 78 Combination anticholinergic/short-acting b2 agonists 79 Short-acting anticholinergics 80 APPENDIX B 81 Bibliography 81 Glossary 86 Report methodology 87




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/228208

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 27/11/2009 05:11:59
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Commercial Insight: Asthma and COPD - Control is the Goal
Web Address:
http://www.researchandmarkets.com/reports/228208
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic €10,208.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 27/11/2009 05:11:59

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)